News | August 17, 2023
Lupin Launches Tiotropium Dry Powder for Inhaler for COPD in US
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Subscribe To Our Newsletter & Stay Updated
